| Charles Edward Smith Jr, MD | |
|
1 Doctors Drive, Greenville, SC 29605 | |
| (864) 572-7001 | |
| (864) 412-0436 |
| Full Name | Charles Edward Smith Jr |
|---|---|
| Gender | Male |
| Speciality | Otolaryngology |
| Experience | 40 Years |
| Location | 1 Doctors Drive, Greenville, South Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1518914993 | NPI | - | NPPES |
| 129943 | Medicaid | SC | |
| P00801257 | Other | SC | RR MEDICARE |
| 040010408 | Other | SC | RAILROAD MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Y00000X | Otolaryngology | 12994 (South Carolina) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Greenville Ent And Allergy Associates Pa | 5395158653 | 20 |
News Archive
A pilot programme for the 'Ambition: Health' scheme is targeting areas of high unemployment that also have NHS skills shortages. It will also offer in-work support to encourage career progression.
More than 120 professionals from the field of health and other experts from thirty-three countries worldwide have taken part in the social awareness event of the EUDONORGAN project, an initiative directly launched by the European Parliament and led by the University of Barcelona, together with the Bosch i Gimpera Foundation and the DTI - TPM Foundation, located at the Barcelona Science Park.
The Center for Medicinal Cannabis Research (CMCR) at University of California San Diego School of Medicine, the nation's oldest research center for scientific inquiry into the safety and efficacy of cannabis, has announced $3 million in research grants to explore new applications of cannabis for a number of novel medical applications.
Using a "chemical nose" array of nanoparticles and polymers, researchers at the University of Massachusetts Amherst have developed a fundamentally new, more effective way to differentiate not only between healthy and cancerous cells but also between metastatic and nonmetastatic cancer cells. It is a tool that could revolutionize cancer detection and treatment, according to Vincent M. Rotello, Ph.D., M.Phil., and D. Joseph Jerry, Ph.D., M.S., the investigators who led the study.
Research by Rutgers Cancer Institute of New Jersey investigators has identified novel functions of the superoxide dismutase 1 (SOD1) enzyme providing support that it could serve as a therapeutic target in the most common type of lung cancer.
› Verified 6 days ago
| Entity Name | Prisma Health University Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1295763217 PECOS PAC ID: 8325950983 Enrollment ID: O20031103000238 |
News Archive
A pilot programme for the 'Ambition: Health' scheme is targeting areas of high unemployment that also have NHS skills shortages. It will also offer in-work support to encourage career progression.
More than 120 professionals from the field of health and other experts from thirty-three countries worldwide have taken part in the social awareness event of the EUDONORGAN project, an initiative directly launched by the European Parliament and led by the University of Barcelona, together with the Bosch i Gimpera Foundation and the DTI - TPM Foundation, located at the Barcelona Science Park.
The Center for Medicinal Cannabis Research (CMCR) at University of California San Diego School of Medicine, the nation's oldest research center for scientific inquiry into the safety and efficacy of cannabis, has announced $3 million in research grants to explore new applications of cannabis for a number of novel medical applications.
Using a "chemical nose" array of nanoparticles and polymers, researchers at the University of Massachusetts Amherst have developed a fundamentally new, more effective way to differentiate not only between healthy and cancerous cells but also between metastatic and nonmetastatic cancer cells. It is a tool that could revolutionize cancer detection and treatment, according to Vincent M. Rotello, Ph.D., M.Phil., and D. Joseph Jerry, Ph.D., M.S., the investigators who led the study.
Research by Rutgers Cancer Institute of New Jersey investigators has identified novel functions of the superoxide dismutase 1 (SOD1) enzyme providing support that it could serve as a therapeutic target in the most common type of lung cancer.
› Verified 6 days ago
| Entity Name | Greenville Health System |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1568532513 PECOS PAC ID: 8123938131 Enrollment ID: O20031212000723 |
News Archive
A pilot programme for the 'Ambition: Health' scheme is targeting areas of high unemployment that also have NHS skills shortages. It will also offer in-work support to encourage career progression.
More than 120 professionals from the field of health and other experts from thirty-three countries worldwide have taken part in the social awareness event of the EUDONORGAN project, an initiative directly launched by the European Parliament and led by the University of Barcelona, together with the Bosch i Gimpera Foundation and the DTI - TPM Foundation, located at the Barcelona Science Park.
The Center for Medicinal Cannabis Research (CMCR) at University of California San Diego School of Medicine, the nation's oldest research center for scientific inquiry into the safety and efficacy of cannabis, has announced $3 million in research grants to explore new applications of cannabis for a number of novel medical applications.
Using a "chemical nose" array of nanoparticles and polymers, researchers at the University of Massachusetts Amherst have developed a fundamentally new, more effective way to differentiate not only between healthy and cancerous cells but also between metastatic and nonmetastatic cancer cells. It is a tool that could revolutionize cancer detection and treatment, according to Vincent M. Rotello, Ph.D., M.Phil., and D. Joseph Jerry, Ph.D., M.S., the investigators who led the study.
Research by Rutgers Cancer Institute of New Jersey investigators has identified novel functions of the superoxide dismutase 1 (SOD1) enzyme providing support that it could serve as a therapeutic target in the most common type of lung cancer.
› Verified 6 days ago
| Entity Name | Baptist Easley Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144452889 PECOS PAC ID: 0840337606 Enrollment ID: O20091027000684 |
News Archive
A pilot programme for the 'Ambition: Health' scheme is targeting areas of high unemployment that also have NHS skills shortages. It will also offer in-work support to encourage career progression.
More than 120 professionals from the field of health and other experts from thirty-three countries worldwide have taken part in the social awareness event of the EUDONORGAN project, an initiative directly launched by the European Parliament and led by the University of Barcelona, together with the Bosch i Gimpera Foundation and the DTI - TPM Foundation, located at the Barcelona Science Park.
The Center for Medicinal Cannabis Research (CMCR) at University of California San Diego School of Medicine, the nation's oldest research center for scientific inquiry into the safety and efficacy of cannabis, has announced $3 million in research grants to explore new applications of cannabis for a number of novel medical applications.
Using a "chemical nose" array of nanoparticles and polymers, researchers at the University of Massachusetts Amherst have developed a fundamentally new, more effective way to differentiate not only between healthy and cancerous cells but also between metastatic and nonmetastatic cancer cells. It is a tool that could revolutionize cancer detection and treatment, according to Vincent M. Rotello, Ph.D., M.Phil., and D. Joseph Jerry, Ph.D., M.S., the investigators who led the study.
Research by Rutgers Cancer Institute of New Jersey investigators has identified novel functions of the superoxide dismutase 1 (SOD1) enzyme providing support that it could serve as a therapeutic target in the most common type of lung cancer.
› Verified 6 days ago
| Entity Name | Greenville Ent And Allergy Associates Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1649875816 PECOS PAC ID: 5395158653 Enrollment ID: O20210105001174 |
News Archive
A pilot programme for the 'Ambition: Health' scheme is targeting areas of high unemployment that also have NHS skills shortages. It will also offer in-work support to encourage career progression.
More than 120 professionals from the field of health and other experts from thirty-three countries worldwide have taken part in the social awareness event of the EUDONORGAN project, an initiative directly launched by the European Parliament and led by the University of Barcelona, together with the Bosch i Gimpera Foundation and the DTI - TPM Foundation, located at the Barcelona Science Park.
The Center for Medicinal Cannabis Research (CMCR) at University of California San Diego School of Medicine, the nation's oldest research center for scientific inquiry into the safety and efficacy of cannabis, has announced $3 million in research grants to explore new applications of cannabis for a number of novel medical applications.
Using a "chemical nose" array of nanoparticles and polymers, researchers at the University of Massachusetts Amherst have developed a fundamentally new, more effective way to differentiate not only between healthy and cancerous cells but also between metastatic and nonmetastatic cancer cells. It is a tool that could revolutionize cancer detection and treatment, according to Vincent M. Rotello, Ph.D., M.Phil., and D. Joseph Jerry, Ph.D., M.S., the investigators who led the study.
Research by Rutgers Cancer Institute of New Jersey investigators has identified novel functions of the superoxide dismutase 1 (SOD1) enzyme providing support that it could serve as a therapeutic target in the most common type of lung cancer.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Charles Edward Smith Jr, MD 1 Doctors Drive, Greenville, SC 29605 Ph: (864) 572-7001 | Charles Edward Smith Jr, MD 1 Doctors Drive, Greenville, SC 29605 Ph: (864) 572-7001 |
News Archive
A pilot programme for the 'Ambition: Health' scheme is targeting areas of high unemployment that also have NHS skills shortages. It will also offer in-work support to encourage career progression.
More than 120 professionals from the field of health and other experts from thirty-three countries worldwide have taken part in the social awareness event of the EUDONORGAN project, an initiative directly launched by the European Parliament and led by the University of Barcelona, together with the Bosch i Gimpera Foundation and the DTI - TPM Foundation, located at the Barcelona Science Park.
The Center for Medicinal Cannabis Research (CMCR) at University of California San Diego School of Medicine, the nation's oldest research center for scientific inquiry into the safety and efficacy of cannabis, has announced $3 million in research grants to explore new applications of cannabis for a number of novel medical applications.
Using a "chemical nose" array of nanoparticles and polymers, researchers at the University of Massachusetts Amherst have developed a fundamentally new, more effective way to differentiate not only between healthy and cancerous cells but also between metastatic and nonmetastatic cancer cells. It is a tool that could revolutionize cancer detection and treatment, according to Vincent M. Rotello, Ph.D., M.Phil., and D. Joseph Jerry, Ph.D., M.S., the investigators who led the study.
Research by Rutgers Cancer Institute of New Jersey investigators has identified novel functions of the superoxide dismutase 1 (SOD1) enzyme providing support that it could serve as a therapeutic target in the most common type of lung cancer.
› Verified 6 days ago
Dr. Augustus J Goforth Iii, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 131 Commonwealth Dr, Suite 230, Greenville, SC 29615 Phone: 864-281-9440 Fax: 864-281-9443 | |
Gustavo Guimaraes Rangel, Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 200 Patewood Dr Ste B400, Greenville, SC 29615 Phone: 864-454-4368 Fax: 864-241-9232 | |
Robert A Wilson, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 4200 E North St Ste 16, Greenville, SC 29615 Phone: 864-292-2800 Fax: 864-292-2921 | |
Edward Benjamin Penn Jr., MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 200 Patewood Dr Ste B400, Greenville, SC 29615 Phone: 864-522-8603 | |
Dr. Ronald T Yuko, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 131 Commonwealth Dr, Suite 290, Greenville, SC 29615 Phone: 864-281-9440 Fax: 864-281-9443 | |
Dr. Robert Lafitte Eller, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1 Doctors Dr, Greenville, SC 29605 Phone: 864-572-7001 Fax: 864-412-0645 | |
Dr. Leighanne Hoskins Dorton, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1 Doctors Dr, Greenville, SC 29605 Phone: 864-572-7001 |